Pasithea Therapeutics Corp. (KTTA) SEC filings
KTTA SEC filings moved a median of -1.25% by the close. KTTA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KTTA overview →
68 measured KTTA SEC filing events.
Where these KTTA SEC filings landedvs 63 measured KTTA SEC filing reactions
| Middle 50% of KTTA SEC filing reactions | -4.51% to +1.82% |
|---|---|
| Median reaction (to close) | -1.25% |
| Measured reactions | 63 |
Point-in-time · zero look-ahead
Half of the 63 KTTA SEC filing events with a measured close landed between -4.51% and +1.82%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Pasithea Therapeutics For: Sep 16 | SEC filing · Form 8-K | +4.91% | +3.41% | |
| Form 8-K Pasithea Therapeutics For: Sep 09 | SEC filing · Form 8-K | +0.09% | -5.20% | |
| Form 8-K Pasithea Therapeutics For: Aug 20 | SEC filing · Form 8-K | -4.74% | -3.48% | |
| Form 10-Q Pasithea Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.55% | -1.85% | |
| Form ARS Pasithea Therapeutics For: Dec 31 | SEC filing · Form ARS | +1.84% | — | |
| Form DEF 14A Pasithea Therapeutics For: Sep 09 | SEC filing · Form DEF | +1.84% | — | |
| Form PRE 14A Pasithea Therapeutics For: Jul 29 | SEC filing · Form PRE | +0.00% | -1.33% | |
| Form 10-Q Pasithea Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.51% | +0.00% | |
| Form 8-K Pasithea Therapeutics For: May 01 | SEC filing · Form 8-K | +2.74% | -2.86% | |
| Form 10-K Pasithea Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.70% | +4.48% | |
| Form 8-K Pasithea Therapeutics For: Feb 20 | SEC filing · Form 8-K | -0.85% | -4.18% | |
| Form S-8 Pasithea Therapeutics | SEC filing · Form S-8 | +0.00% | -0.56% | |
| Form 8-K Pasithea Therapeutics For: Jan 28 | SEC filing · Form 8-K | -0.02% | +0.62% | |
| Form EFFECT Pasithea Therapeutics | SEC filing · Form EFFECT | +0.83% | +1.54% | |
| Form POS AM Pasithea Therapeutics | SEC filing · Form POS | +0.03% | -1.25% | |
| Form DEF 14A Pasithea Therapeutics For: Jan 28 | SEC filing · Form DEF | -0.22% | +0.00% | |
| Form PRE 14A Pasithea Therapeutics For: Jan 28 | SEC filing · Form PRE | +1.77% | +4.42% | |
| Form 8-K Pasithea Therapeutics For: Dec 12 | SEC filing · Form 8-K | +0.00% | +3.57% | |
| Form 8-K Pasithea Therapeutics For: Nov 28 | SEC filing · Form 8-K | +0.00% | +3.48% | |
| Form EFFECT Pasithea Therapeutics | SEC filing · Form EFFECT | -3.57% | -7.94% | |
| Form S-1/A Pasithea Therapeutics | SEC filing · Form S-1 | +27.59% | +1.38% | |
| Form 8-K Pasithea Therapeutics For: Nov 20 | SEC filing · Form 8-K | +8.47% | +107.84% | |
| Form S-1 Pasithea Therapeutics | SEC filing · Form S-1 | -1.85% | -4.84% | |
| Form 8-K Pasithea Therapeutics For: Nov 04 | SEC filing · Form 8-K | -4.26% | -5.77% | |
| Form 8-K Pasithea Therapeutics For: Oct 24 | SEC filing · Form 8-K | +0.14% | +4.64% | |
| Form 8-K Pasithea Therapeutics For: Sep 16 | SEC filing · Form 8-K | +0.24% | +0.61% | |
| Form S-8 Pasithea Therapeutics | SEC filing · Form S-8 | -2.59% | +2.26% | |
| Form 8-K Pasithea Therapeutics For: Sep 03 | SEC filing · Form 8-K | +2.01% | -1.73% | |
| Form 10-Q Pasithea Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +1.18% | +0.03% | |
| Form ARS Pasithea Therapeutics For: Dec 31 | SEC filing · Form ARS | -4.39% | -2.23% | |
| Form DEF 14A Pasithea Therapeutics For: Sep 03 | SEC filing · Form DEF | -4.39% | -2.23% | |
| Form PRE 14A Pasithea Therapeutics For: Sep 03 | SEC filing · Form PRE | +0.10% | -0.62% | |
| Form 8-K Pasithea Therapeutics For: Jul 10 | SEC filing · Form 8-K | -0.62% | +0.10% | |
| Form 8-K Pasithea Therapeutics For: Jun 23 | SEC filing · Form 8-K | +0.50% | +2.59% | |
| Form 8-K Pasithea Therapeutics For: Jun 20 | SEC filing · Form 8-K | +1.82% | +1.31% | |
| Form 10-Q Pasithea Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +28.25% | +12.47% | |
| Form 8-K Pasithea Therapeutics For: May 06 | SEC filing · Form 8-K | -1.09% | -14.29% | |
| Form EFFECT Pasithea Therapeutics | SEC filing · Form EFFECT | -7.05% | -20.42% | |
| Form S-1 Pasithea Therapeutics | SEC filing · Form S-1 | -7.50% | -5.00% | |
| Form 8-K Pasithea Therapeutics For: Apr 23 | SEC filing · Form 8-K | +3.30% | -1.17% | |
| Form 10-K Pasithea Therapeutics For: Dec 31 | SEC filing · Form 10-K | -3.15% | -1.57% | |
| Form 8-K Pasithea Therapeutics For: Nov 26 | SEC filing · Form 8-K | +0.00% | -6.15% | |
| Form 10-Q Pasithea Therapeutics For: Sep 30 | SEC filing · Form 10-Q | — | -2.94% | |
| Form EFFECT Pasithea Therapeutics | SEC filing · Form EFFECT | +0.00% | -13.94% | |
| Form S-3 Pasithea Therapeutics | SEC filing · Form S-3 | — | -7.83% | |
| Form 8-K Pasithea Therapeutics For: Sep 26 | SEC filing · Form 8-K | -0.19% | -11.75% | |
| Form 8-K Pasithea Therapeutics For: Sep 26 | SEC filing · Form 8-K | -3.52% | -17.61% | |
| Form 10-Q Pasithea Therapeutics For: Jun 30 | SEC filing · Form 10-Q | — | -3.75% | |
| Form 8-K Pasithea Therapeutics For: Jun 26 | SEC filing · Form 8-K | — | +8.68% | |
| Form ARS Pasithea Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.00% | -1.56% | |
| Form DEF 14A Pasithea Therapeutics For: Jun 26 | SEC filing · Form DEF | +0.00% | -1.56% | |
| Form 10-Q Pasithea Therapeutics For: Mar 31 | SEC filing · Form 10-Q | — | +1.06% | |
| Form 8-K Pasithea Therapeutics For: May 13 | SEC filing · Form 8-K | — | +1.06% | |
| Form EFFECT Pasithea Therapeutics | SEC filing · Form EFFECT | — | +11.75% | |
| Form 10-K Pasithea Therapeutics For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form POS AM Pasithea Therapeutics | SEC filing · Form POS | — | — | |
| Form S-8 Pasithea Therapeutics | SEC filing · Form S-8 | — | — | |
| Form 8-K Pasithea Therapeutics For: Jan 17 | SEC filing · Form 8-K | — | +2.96% | |
| Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position | Press release | +0.43% | +5.03% | |
| Form 8-K Pasithea Therapeutics For: Dec 29 | SEC filing · Form 8-K | +3.76% | -1.55% | |
| Form 8-K Pasithea Therapeutics For: Dec 28 | SEC filing · Form 8-K | -2.06% | -4.98% | |
| Form DEFA14A Pasithea Therapeutics | SEC filing · Form DEFA14A | +4.28% | -3.54% | |
| Form 8-K Pasithea Therapeutics For: Dec 19 | SEC filing · Form 8-K | +4.22% | +1.82% | |
| Form DEFA14A Pasithea Therapeutics | SEC filing · Form DEFA14A | +4.22% | +1.82% | |
| Form DEFA14A Pasithea Therapeutics | SEC filing · Form DEFA14A | -1.51% | -5.07% | |
| Form 10-Q Pasithea Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +8.67% | |
| Form ARS Pasithea Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.00% | -6.13% | |
| Form DEF 14A Pasithea Therapeutics For: Nov 29 | SEC filing · Form DEF | +0.00% | -6.13% |
Keep exploring
More KTTA: earnings → · analyst actions → · KTTA overview →